LANTHEUS MEDCL Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LANTHEUS MEDCL, and what generic alternatives to LANTHEUS MEDCL drugs are available?
LANTHEUS MEDCL has nine approved drugs.
There are ten US patents protecting LANTHEUS MEDCL drugs.
There are seventy-two patent family members on LANTHEUS MEDCL drugs in seventeen countries and eight supplementary protection certificates in five countries.
Summary for LANTHEUS MEDCL
| International Patents: | 72 |
| US Patents: | 10 |
| Tradenames: | 10 |
| Ingredients: | 8 |
| NDAs: | 9 |
Drugs and US Patents for LANTHEUS MEDCL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lantheus Medcl | DEFINITY | perflutren | INJECTABLE;INTRAVENOUS | 021064-001 | Jul 31, 2001 | RX | Yes | Yes | 10,583,207 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lantheus Medcl | ABLAVAR | gadofosveset trisodium | SOLUTION;INTRAVENOUS | 021711-002 | Dec 22, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Lantheus Medcl | ABLAVAR | gadofosveset trisodium | SOLUTION;INTRAVENOUS | 021711-001 | Dec 22, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Lantheus Medcl | THALLOUS CHLORIDE TL 201 | thallous chloride tl-201 | INJECTABLE;INTRAVENOUS | 017806-002 | Oct 9, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LANTHEUS MEDCL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lantheus Medcl | DEFINITY | perflutren | INJECTABLE;INTRAVENOUS | 021064-001 | Jul 31, 2001 | 5,769,080 | ⤷ Sign Up |
| Lantheus Medcl | DEFINITY | perflutren | INJECTABLE;INTRAVENOUS | 021064-001 | Jul 31, 2001 | 5,527,521 | ⤷ Sign Up |
| Lantheus Medcl | ABLAVAR | gadofosveset trisodium | SOLUTION;INTRAVENOUS | 021711-002 | Dec 22, 2008 | 7,229,606 | ⤷ Sign Up |
| Lantheus Medcl | ABLAVAR | gadofosveset trisodium | SOLUTION;INTRAVENOUS | 021711-002 | Dec 22, 2008 | 8,394,356 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LANTHEUS MEDCL Drugs
Supplementary Protection Certificates for LANTHEUS MEDCL Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0806968 | PA2007003 | Lithuania | ⤷ Sign Up | PRODUCT NAME: GADOFOSVESETUM TRINATRICUM; REG NO/DATE: EU/1/05/313/001-009 20051005 |
| 0806968 | PA2007003,C0806968 | Lithuania | ⤷ Sign Up | PRODUCT NAME: GADOFOSVESETUM TRINATRICUM; REGISTRATION NO/DATE: EU/1/05/313/001, 2005 10 05 EU/1/05/313/002, 2005 10 05 EU/1/05/313/003, 2005 10 05 EU/1/05/313/004, 2005 10 05 EU/1/05/313/005, 2005 10 05 EU/1/05/313/006, 2006 10 05 EU/1/05/313/007, 2005 10 05 EU/1/05/313/008, 2005 10 05 EU/1/05/313/00 2005100 |
| 0712293 | 0790017-8 | Sweden | ⤷ Sign Up | PRODUCT NAME: LIPIDMIKROSFAERER INNEHALLANDE PERFLUTREN; REG. NO/DATE: EU/1/06/361/001 20060920 |
| 0712293 | C300267 | Netherlands | ⤷ Sign Up | PRODUCT NAME: PERFLUTREN BEVATTENDE LIPIDE-MICROBOLLEN; REGISTRATION NO/DATE: EU/1/06/361/001 20060920 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
